HERITAGE CANNABIS HLDGS Stock Price, News & Analysis

Heritage Cannabis Holdings Corp. (CSE: CANN, OTCQX: HERTF) has announced a definitive white label agreement with BRNT Ltd. to launch Violet Tourist branded cannabis 2.0 infused pre-rolls in Alberta, aiming for nationwide distribution. The agreement gives Heritage control over procurement and supply chain, facilitating expansion into cannabis 1.0 formats. Violet Tourist has already generated over $2.5 million in wholesale revenue since its December 2020 launch and ranked as the #4 pre-roll brand in Alberta as of August 2021. This partnership reinforces Heritage's commitment to the growing cannabis market in Canada.

Heritage Cannabis Holdings Corp. (OTCQX: HERTF) reports a third consecutive record gross revenue quarter, expecting a 20-25% increase in Q4 revenue compared to Q3. The company is focused on cost reduction and aims to achieve cash-flow positivity in early 2022. Heritage's sales growth has been impressive, with a compound annual growth rate (CAGR) of over 16% from February to August 2021, significantly higher than the average 3% for top Canadian Licensed Producers. CEO David Schwede emphasizes the company's commitment to advancing sales and maintaining prudent financial management.

Heritage Cannabis Holdings Corp. (CSE: CANN, OTCQX: HERTF) has finalized a Note and Warrant Purchase Agreement with Merida Capital Partners, securing USD$1.5 million to enter the Missouri market. The agreement includes a USD$660,000 promissory note maturing on October 18, 2023, at a 15% interest rate, payable in common shares. The conversion price for shares will be CAD$0.07 or the higher closing price before issuance. Additionally, 696,942 shares were issued as a commitment fee, valuing USD$31,250. All securities remain under a four-month hold.

Heritage Cannabis Holdings Corp. (OTCQX: HERTF) reports robust growth in Canadian sales, ranking #4 in concentrates, #6 in oils, and #9 in vapes. Sales growth accelerated, with unaudited August sales at approximately $2.5 million despite local forest fire disruptions. The company has made significant progress in its U.S. expansion, with construction at its Missouri facility underway. Heritage aims to penetrate 60% of the Canadian cannabis market through new product launches, expecting first revenue from Missouri in Q1 2022, further enhancing growth prospects.

Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) has signed a joint venture agreement with Noble Growth Corp. to strengthen its position in Canada's premium dried flower market. Noble will cultivate sought-after strains for Heritage's RAD Reefer Reserve and Pura Vida Legacy brands. With over 300 genetics known for high THC and terpenes, this collaboration aims to enhance market share and profitability. Heritage has been successful in the concentrate and oil sectors and intends to replicate this success in the flower category, targeting strong revenue streams.

Heritage Cannabis Holdings Corp. (OTCQX: HERTF) announced an exclusive partnership between its subsidiary Opticann and C.A.R.P. to promote medical cannabis education among over 320,000 members. Through this collaboration, Opticann will feature the C.A.R.P. Recommended Seal, and members will enjoy a 15% discount on various CB4 products, including capsules and topical gels. This partnership aims to improve knowledge of medical cannabis benefits, especially for chronic pain and anxiety, while enhancing product visibility through C.A.R.P.'s channels.

Heritage Cannabis Holdings Corp. has amended its loan agreement with BJK Holdings Ltd., increasing the original loan from $7.0 million to $7.175 million and extending the maturity date to February 1, 2023. An additional $2.6 million was also advanced to support capital asset acquisitions and operations. A revolving credit line of $5.0 million was established with an 18% interest rate. Overall, the company can access $14.775 million through this agreement. The CEO emphasized the importance of these funds for growth in the Canadian cannabis market.

Heritage Cannabis Holdings Corp. (OTCQX: HERTF) announces its subsidiary Opticann has completed its first shipment of medical cannabis CBD filmstrips worth $60,000 to Australia. This shipment follows two supply agreements with established Australian firms, capitalizing on a market expected to grow over 30% CAGR through 2028, as per Grand View Research. The CBD filmstrips, produced under Canada’s GPP conditions, utilize IntelGenx’s VersaFilm® technology, offering rapid onset and enhanced bioavailability. Heritage aims to strategically expand in Australia while strengthening its Canadian market presence.

Heritage Cannabis Holdings Corp. (OTCQX: HERTF) reported record gross revenue of $5.1 million for Q3 2021, a 114% year-over-year increase. Gross profit reached $1.2 million, marking a significant turnaround from a loss of $1.1 million in Q3 2020. Despite challenges from forest fires affecting production, the company expanded its product offerings, launching into the flower market and gaining market share in concentrates and vapes. However, SG&A costs surged to 93% of revenue due to one-time costs and competitive pricing strategies, raising concerns about sustainability.